Summary of HR 3873 - KO Cancer Act

Bill Overview

• Bill Number: HR 3873
• Title: KO Cancer Act
• Status: Introduced in House
• Introduced Date: June 10, 2025
• Classification: Bill

Purpose and Intent

The KO Cancer Act aims to enhance the fight against cancer through increased funding and support for research, prevention, and treatment initiatives. The bill seeks to improve patient outcomes and reduce the overall burden of cancer on individuals and healthcare systems.

Key Provisions

While the specific text of the bill is not provided, the following key provisions are typically included in similar legislation aimed at combating cancer:

1. Increased Funding for Research:

   • Allocates federal funds to cancer research initiatives, focusing on innovative treatments and therapies.

2. Support for Preventive Measures:

   • Encourages programs aimed at cancer prevention, including public awareness campaigns and screening initiatives.

3. Access to Treatment:

   • Proposes measures to improve access to cancer treatments for underserved populations, ensuring equitable healthcare delivery.

4. Collaboration with Healthcare Providers:

   • Establishes partnerships with healthcare providers and institutions to facilitate research and improve patient care.

5. Data Collection and Analysis:

   • Mandates the collection of data on cancer incidence and outcomes to inform future policy and funding decisions.

Who Would Be Affected

• Patients: Individuals diagnosed with cancer would benefit from improved treatment options and access to care.
• Healthcare Providers: Hospitals and clinics may receive additional funding and resources to enhance cancer care services.
• Researchers: Increased funding would support researchers working on innovative cancer therapies and preventive measures.
• Public Health Organizations: Organizations focused on cancer prevention and education would gain resources to expand their outreach efforts.

Procedural Aspects

• Committee Referrals:

  • The bill was referred to the Committee on Appropriations and the Committee on Energy and Commerce for further consideration. The Speaker will determine the timeline for these committees to review the bill.

• Next Steps:

  • Following committee review, the bill may be subject to amendments before being brought to the House floor for a vote.

Sponsors

• Primary Sponsor: Brian K. Fitzpatrick
• Cosponsor: Debbie Dingell

Conclusion

The KO Cancer Act represents a significant legislative effort to combat cancer through enhanced funding and support for research, prevention, and treatment initiatives. As the bill progresses through the legislative process, it has the potential to make a meaningful impact on cancer care and patient outcomes across the nation.